🇮🇱 Saphnelo in Israel

Saphnelo (ANIFROLUMAB) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Saphnelo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Israel

Frequently asked questions

Is Saphnelo approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Saphnelo in Israel?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.